Literature DB >> 15342937

Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.

Araceli Encabo1, Pilar Solves, Emilia Mateu, Pilar Sepúlveda, Francisco Carbonell-Uberos, María Dolores Miñana.   

Abstract

There is a growing interest in generating dendritic cells (DCs) for using as vaccines. Several cytokines, especially stem cell factor (SCF) and FLT3-ligand (FL), have been identified as essential to produce large numbers of myeloid precursors and even to increase DC yield obtained by the action of granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor alpha (TNF-alpha). However, there are few studies on the effect of the early-acting cytokines, commonly used to expand CD34+ progenitor cells, on DC generation. We report here that in the absence of serum, SCF, FL, and thrombopoietin (TPO) plus interleukin-6 (IL-6) and SCF, FL, and TPO plus IL-3 were able to generate CD14+CD1a- and CD14- CD1a+ myeloid DC precursors from CD34+ cells, but IL-6 had an inhibitory effect on the generation of CD14- CD1a+ cells. Both DC precursors differentiated into mature DCs by GM-CSF, IL-4, and TNF-alpha, and DCs obtained from both types of culture exhibited equal allostimulatory capacity. CD1a+ DCs generated could be identified on the basis of DC-specific intracellular adhesion molecule-grabbing nonintegrin (DC-SIGN) expression, a novel C-type lectin receptor expressed on dermal DCs but not on Langerhans cells. In addition, the inclusion of IL-3 to the culture medium induced the appearance of CD13- cells that differentiated into plasmacytoid DC (DC2) on the addition of TNF-alpha, allowing the identification of developmental stages of DC2. Like true plasmacytoid DCs, these cells secreted interferon-alpha after TLR9-specific stimulation with a specific CpG nucleotide.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342937     DOI: 10.1634/stemcells.22-5-725

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  11 in total

1.  Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.

Authors:  Colin de Haar; Maud Plantinga; Nina Jg Blokland; Niek P van Til; Thijs Wh Flinsenberg; Viggo F Van Tendeloo; Evelien L Smits; Louis Boon; Lotte Spel; Marianne Boes; Jaap Jan Boelens; Stefan Nierkens
Journal:  Oncoimmunology       Date:  2015-05-27       Impact factor: 8.110

2.  Evaluation of prolonged fatigue post-West Nile virus infection and association of fatigue with elevated antiviral and proinflammatory cytokines.

Authors:  Melissa N Garcia; Anne M Hause; Christopher M Walker; Jordan S Orange; Rodrigo Hasbun; Kristy O Murray
Journal:  Viral Immunol       Date:  2014-07-25       Impact factor: 2.257

Review 3.  Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytes.

Authors:  Angelo Aquino; Grazia Graziani; Ornella Franzese; Salvatore P Prete; Enzo Bonmassar; Laura Bonmassar; Stefania D'Atri
Journal:  Clin Dev Immunol       Date:  2011-03-22

4.  Kinetics of progenitor hemopoetic stem cells in sepsis: correlation with patients survival?

Authors:  Thomas Tsaganos; Evangelos J Giamarellos-Bourboulis; Spyridon Kollias; Dimitrios Zervakis; Vassiliki Karagianni; Aimilia Pelekanou; Ekaterini-Christina Tampaki; Marina Kontogiorgi; Apostolos Koroneos; Nikolaos Drakoulis; Apostolos Armaganidis; Charis Roussos; Helen Giamarellou
Journal:  BMC Infect Dis       Date:  2006-09-18       Impact factor: 3.090

Review 5.  The Hematopoietic Stem/Progenitor Cell Response to Hemorrhage, Injury, and Sepsis: A Review of Pathophysiology.

Authors:  Lauren S Kelly; Dijoia B Darden; Brittany P Fenner; Philip A Efron; Alicia M Mohr
Journal:  Shock       Date:  2021-07-01       Impact factor: 3.533

6.  Exogenous addition of arachidonic acid to the culture media enhances the functionality of dendritic cells for their possible use in cancer immunotherapy.

Authors:  Jeetendra Kumar; Rupali Gurav; Vaijayanti Kale; Lalita Limaye
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

7.  Dendritic Cell (DC) Vaccine in Mouse Lung Cancer Minimal Residual Model; Comparison of Monocyte-derived DC vs. Hematopoietic Stem Cell Derived-DC.

Authors:  Soyoung Baek; Seog Jae Lee; Myoung Joo Kim; Hyunah Lee
Journal:  Immune Netw       Date:  2012-12-31       Impact factor: 6.303

Review 8.  The achilles heel of the trojan horse model of HIV-1 trans-infection.

Authors:  Marielle Cavrois; Jason Neidleman; Warner C Greene
Journal:  PLoS Pathog       Date:  2008-06-27       Impact factor: 6.823

9.  A Human Cell Line Model for Interferon-α Driven Dendritic Cell Differentiation.

Authors:  Jurjen M Ruben; Lindy L Visser; Kimberley M Heinhuis; Tom O'Toole; Hetty J Bontkes; Theresia M Westers; Gert J Ossenkoppele; Tanja D de Gruijl; Arjan A van de Loosdrecht
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

10.  Increased CD83 expression of CD34-positive monocytes in donors during peripheral blood stem cell mobilization in humans.

Authors:  Hideki Nakasone; Misato Kikuchi; Koji Kawamura; Yu Akahoshi; Miki Sato; Shunto Kawamura; Nozomu Yoshino; Junko Takeshita; Kazuki Yoshimura; Yukiko Misaki; Ayumi Gomyo; Aki Tanihara; Machiko Kusuda; Masaharu Tamaki; Shun-Ichi Kimura; Shinichi Kako; Yoshinobu Kanda
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.